UAE medical and donor requirements for assisted reproduction
UAE fertility treatment rules: clinical eligibility, medical safety certificate, consent, donor eggs and sperm, genetic screening and the Dubai surrogacy ban.
The short answer
There is no single clinic checklist that can be safely applied across every emirate. The federal framework is Federal Law No. 7 of 2019 on Medically Assisted Reproduction, as amended, its executive regulation and decisions made by the relevant health authority. The answer depends on the treatment, the people involved, whose eggs and sperm would be used, and where the clinic is licensed. As at 24 October 2026, the Dubai Health Authority’s Assisted Reproductive Medicine Center Standards, effective 28 February 2026, expressly prohibit transferring an embryo to another woman’s uterus and restrict third-party reproductive material. Do not treat a clinic advertisement, a general statement that UAE law changed in 2023, or a successful appointment as proof that a proposed donor or surrogacy arrangement is lawful.
Which rules control
Start with the federal law and then check the rules and approvals of the emirate and health authority regulating the actual facility. Article 2 permits emirates to regulate assisted reproduction under local legislation, but expressly preserves federal Articles 6–14 and 17; do not assume local rules displace those provisions. The official federal text sets the baseline for treatment, consent, donor-gamete combinations, and preservation of reproductive material. Cabinet Resolution No. 64 of 2020 supplies executive rules and was amended by Cabinet Resolution No. 124 of 2024. A local regulator can impose operational standards on facilities within its remit; the current Dubai standards are especially important if treatment would take place in a DHA-regulated centre. A rule that applies in Dubai must not automatically be described as the rule in Abu Dhabi or every other emirate. The current federal framework does not, by itself, establish a complete authorisation or regulatory regime for surrogacy, or resolve contract enforceability and parentage.
Donor eggs and donor sperm
For married couples, Article 9 of the federal law prohibits fertilisation using the husband’s sperm with an egg from a woman other than his wife, and fertilisation using the wife’s egg with sperm from a man other than her husband. The law also allows the Cabinet to identify additional prohibited cases. Article 14 restricts commercial use of unfertilised or fertilised eggs and frozen sperm, non-therapeutic genetic modification, and disposal of this material to third parties. These are legal restrictions, not optional clinic preferences, and consent alone does not cure a prohibited arrangement.
Importantly, Article 9 begins “without prejudice to” Article 8(2), under which qualifying non-Muslim parties without a marriage certificate may seek permission. The listed married-couple prohibitions therefore should not simply be applied to that route without analysis. But the cross-reference does not by itself settle donor-gamete eligibility: Article 14 separately prohibits disposing of eggs and frozen sperm to third parties, and DHA standard §18.1.5 prohibits using fresh or frozen gametes/embryos for others. Published rules do not settle how these provisions interact for every proposed donor arrangement, particularly outside DHA jurisdiction. Do not infer permission from the 2023 amendment alone; obtain written, case-specific confirmation from the competent health authority and UAE-qualified counsel before proceeding.
Applicants without a marriage certificate
Article 8(2) allows non-Muslim involved parties who do not have a marriage certificate to petition the health authority for permission to use assisted-reproduction techniques. The route is conditional: it requires an acknowledgement concerning the child’s lineage, certified by the competent authority in the country of citizenship of the parent to whom the child is to acquire nationality, using the applicable form. It is not an automatic entitlement and it does not remove medical, consent, licensing or other restrictions. In Dubai, the 2026 standards require both non-married individuals to attend for the relevant forms and approvals; the parentage declaration must be signed and sealed by their embassy or consulate and by the UAE Ministry of Foreign Affairs, and the facility must submit the file to DHA for approval. The listed file includes the declaration, facility request, signed freezing and treatment-consent forms, recent medical reports, Emirates ID copies and proof of religion. Confirm current forms and instructions directly with DHA before booking.
Clinical eligibility and timing
Treatment must be clinically appropriate, not merely commercially available. The federal framework and Dubai standards require the centre to consider whether assisted reproduction is the most appropriate medical intervention after assessing whether natural conception is possible or a medical indication supports treatment, and whether an adequate opportunity for natural pregnancy has been allowed. The reviewed standards do not set one universal waiting period for every patient. The treating team selects the technique based on the clinical facts; IVF, ICSI, intrauterine insemination, stimulation and associated procedures are not interchangeable options. There is no legal basis for inventing one universal age cut-off, ovarian-reserve threshold, sperm parameter or number of failed cycles that applies to every patient and every emirate. Ask the clinic to identify the clinical criterion it is applying and whether it comes from legislation, a regulator’s standard, a specialist assessment or its own protocol.
Medical safety assessment and certificate
Before treatment, the physician must assess contraindications, risk factors and whether the patient is fit for the proposed procedure and treatment journey. Article 8 also requires a certificate from a specialised physician stating that the procedure does not pose a danger to the wife’s or foetus’s life or serious harm to their health within medically accepted limits. This is a medical-safety requirement, not a promise of pregnancy or a guarantee that complications will not occur. The clinic should explain what tests or specialist opinions are needed in the individual case, why they are needed, and whether a finding would delay or rule out a particular procedure. Dubai’s standards require recent medical reports in the file for non-married applicants using the local approval route. The exact clinical work-up depends on the proposed technique and the patient’s history; do not assume every test is mandatory for everyone.
Consent and information before treatment
Written consent must be obtained in person at the centre before each procedure, including cryopreservation, under the current Dubai standards. The federal law requires detailed information about the selected technique, its stages, possible negative effects or complications, the financial cost and the realistic pregnancy rate for comparable cases at that centre. Consent should identify what will happen to eggs, sperm or embryos, what may be stored, the applicable storage period, what renewal requires, and what happens if a relationship ends or a person dies. Ask for copies of every form before signing, including separate freezing or storage consent where applicable. A general clinic consent form or a verbal assurance is not a substitute for the prescribed documents or regulatory approval. Do not sign a form with blank fields or accept an unexplained waiver of statutory restrictions.
Genetic screening is conditional
Genetic screening is not an automatic legal prerequisite for every fertility cycle. Under the Dubai standards, screening of gametes or embryos may be carried out with approval of a licensed specialist and the consent of the person from whom sperm or unfertilised eggs are obtained, for the stated purposes of identifying or preventing hereditary disease, avoiding chromosomally abnormal embryos, or sex selection only for family balance or avoidance of genetic disease. Pre-implantation genetic testing requires a documented clinical need identified by a genetic counsellor or an affiliated genetic laboratory, a multidisciplinary team including a reproductive specialist, embryologist and genetic counsellor, and signed consent. The clinic must explain the procedure and side effects, the possibility of false results, and that testing does not guarantee pregnancy or prevent miscarriage; costs and emotional effects should also be discussed. HLA matching requires a medical report from the physician treating the affected patient. Ask which exact indication supports a proposed test and whether it is optional, clinically recommended or required by the regulator.
Storage, renewal and handling of reproductive material
The federal law provides for preservation of fertilised eggs for five years, renewable for similar periods on a written request from both spouses under the applicable rules. Unfertilised eggs and sperm may also be preserved for five years, renewable for a similar period on the written request of the relevant persons. The detailed consent forms, notification process and facility controls are governed by the executive regulation and current health-authority rules. Storage is not permission to use material for any purpose: the law restricts use, transfer to third parties and commercial purposes, and sets out circumstances in which material must be destroyed, including specified death, relationship-termination, request or expiry situations. Before freezing, ask the clinic to state the start and end dates, renewal deadline, who must sign, what happens if consent cannot be obtained, and which approvals are needed for transfer into or out of the UAE. Get the answers in writing and retain the signed forms.
Surrogacy: the confirmed Dubai rule
The current DHA standards expressly prohibit a centre from fertilising a husband’s or concerned party’s sperm with the wife’s or concerned party’s egg and then implanting that embryo in another woman’s uterus. They also prohibit a third-party gamete combination followed by implantation in another woman, and restrict using fresh or frozen gametes or embryos for others or for commercial purposes. These standards apply to DHA-regulated assisted-reproduction services in Dubai and became effective on 28 February 2026. A clinic in Dubai cannot bypass this restriction by describing the arrangement as gestational carrying, obtaining private consent, or using the intended parents’ own gametes. For another emirate, do not infer permission from the 2023 federal amendment or from Dubai’s rule. The local legislation, health-authority standards and approvals must be checked for the precise location. The sources do not establish a uniform, complete surrogacy authorisation for every emirate.
Law versus clinic policy
A clinic may set additional clinical thresholds, request extra investigations, require a particular document format, or decline a case for a documented medical reason. Those operational requirements are not automatically separate statutory rules, and they cannot legalise something federal law or a binding local standard prohibits. Ask the centre to label each requirement as one of: federal legislation, executive regulation, local health-authority standard, individual medical judgement, or clinic protocol. If the clinic says a donor or carrier arrangement is permitted, ask for the exact current provision and written confirmation from the regulator, not just a sales brochure or a message from an agent. A claimed approval should identify the patient category, proposed technique, source of each gamete, intended gestational recipient and facility licence. Verify the licence independently with the competent authority.
Decision matrix: what to verify first
Use this matrix as a first screening tool, not as a substitute for approval. The location of treatment and the exact source of eggs and sperm are decisive facts. Article 9 preserves that route from its listed married-couple prohibitions, but it is not a blanket donor-gamete permission: Article 14 and DHA §18.1.5 impose separate restrictions, so confirm the exact plan in writing. Dubai’s surrogate-carrier prohibition is a local rule for DHA-regulated services. If the clinic cannot explain which authority governs it, pause before paying or sending biological material.
| Situation | What the reviewed rules say | Safe next action |
|---|---|---|
| Married applicants using their own gametes | Proof of ongoing marriage, in-person written consent and clinical safety requirements apply; the combinations specified in Article 9 are prohibited. | Confirm the exact medical work-up and local facility checklist. |
| Non-married non-Muslim applicants | Article 8(2) allows an application to the health authority with the prescribed parentage acknowledgement; Dubai requires local forms and DHA approval. | Get the current form and written approval before treatment. |
| Donor eggs or donor sperm | Article 9 preserves the Article 8(2) route from the listed married-couple prohibitions, but Article 14 and DHA §18.1.5 impose separate restrictions; confirm the specific donor plan in writing. | Do not proceed without a specific current legal basis and regulator confirmation. |
| A gestational carrier in Dubai | DHA standards prohibit embryo implantation into another woman’s uterus in DHA-regulated services. | Do not arrange a Dubai procedure; obtain emirate-specific legal advice elsewhere. |
Before paying or starting a cycle
Ask the centre for its full legal name, licence number, regulator and confirmation that its licence covers the specific procedure. Provide the correct facts about marital status, religion where legally relevant, nationality, residence, prior treatment and any proposed use of stored material. Request a written list of required medical reports, tests, specialist certificates, consents and authority approvals. For a non-married application in Dubai, confirm the current parentage declaration form, embassy or consulate and Ministry of Foreign Affairs formalities, and the DHA submission route. Ask the clinician to explain the clinical indication, alternatives, material risks, realistic centre-specific outcomes, total cost and cancellation or storage terms. For any proposed donor or surrogate, require the clinic to identify the exact legal provision and regulator approval before you sign, pay, travel or arrange a transfer.
Red flags and safe next steps
Pause if an intermediary promises a guaranteed result, says consent can override the law, refuses to name the licensed centre, or claims that the 2023 amendment made all forms of surrogacy and donation legal across the UAE. Do not send embryos, eggs or sperm across borders on the strength of an agent’s message; transfer may require regulator approval and additional rules apply. Keep copies of medical records, the written treatment plan, consent forms, the clinic’s licence details and every approval. Ask a UAE lawyer with current experience in the relevant emirate to check the proposed route before committing funds. If a clinic refuses to identify the legal basis, seek written clarification from the health authority. Parentage, birth registration, nationality, immigration and enforceability of any agreement are separate questions and are not resolved merely because a medical procedure is offered.
Scope, date and remaining checks
This guide reflects official materials located and checked as at 24 October 2026, including the federal legislation text available through the UAE legislation portal and the DHA centre standards effective 28 February 2026. The portal warns that the Arabic legislation prevails if it conflicts with the English translation. The full attachment for Cabinet Resolution No. The local position outside DHA jurisdiction also needs direct verification.
Official legal and regulatory sources
- S1 — Federal Law No. (7) of 2019 Concerning Medically Assisted Reproduction
- S2 — Cabinet Resolution No. (64) of 2020 on the Executive Regulation of Federal Law No. (7) of 2019
- S3 — Dubai Health Authority, Standards for Assisted Reproductive Medicine Centers, Version 1.0
- S4 — Dubai Health Authority circular CIR-2026-00000047, Standards for Assisted Reproductive Medicine Center
- S5 — Federal Decree-Law No. (17) of 2023 amending some provisions of Federal Law No. (7) of 2019 regarding Medical Reproduction Assistance
